视觉结局支持对微小视力损害或骨质增生的蝶眶脑膜瘤患者手术
该连续病例系列纳入2015年5月至2019年1月由神经外科与眶外科医生团队手术的19例WHO I级蝶眶脑膜瘤患者,经翼点入路,中位随访2.4年。术前视力缺损者70%恢复正常、10%改善;术前视野缺损者全部恢复正常;术前突眼44%恢复正常、56%改善。术前视力较差和多数脑膜瘤是长期视力较差的预测因素;骨质增生直径较大和Simpson分级较高是长期视野较差的预测因素。
要点
- 蝶眶脑膜瘤术后视力、视野和突眼多数改善,长期稳定率95%。
- 术前视力较差和多数脑膜瘤 predict 长期视力较差。
- 骨质增生直径较大和Simpson分级较高 predict 长期视野较差。
核心结论
- 建议对蝶眶脑膜瘤患者手术,即使视力损害轻微或仅有骨质增生,因为已有视力功能恶化或广泛骨质增生者术后视觉结局较难恢复正常。
研究设计与样本
- 连续病例系列,2015年5月至2019年1月由一名神经外科医生和一名眶外科医生团队手术,共19例患者(均为WHO I级),经翼点入路,中位随访2.4年。
主要发现
- 术前视力缺损(n=10)中70%恢复正常、10%改善(术前中位数0.8,术后1.2,p=0.021)。
- 术前视野缺损(n=8)全部恢复正常(术前-6.5 dB,术后-1.5 dB,p=0.008)。
- 术前突眼(n=16)中44%恢复正常、56%改善(术前5 mm,术后2 mm,p<0.001)。
- 长期随访中95%患者BCVA和视野保持稳定,21%患者突眼进展。
关键数值与推荐
- 长期(>12个月)BCVA较差的预测因素:术前BCVA较差(p=0.002)和多发脑膜瘤诊断(p=0.021)。
- 长期视野较差的预测因素:骨质增生直径较大(p=0.009)和Simpson分级较高(p=0.032)。
- 短期(3个月)突眼的预测因素:术前突眼(p=0.006)。
临床怎么用
- 对蝶眶脑膜瘤患者应积极考虑手术,不应因视力损害轻微或仅有骨质增生而延迟。
- 术前应评估BCVA、视野、突眼程度、骨质增生直径和Simpson分级以预测术后视觉结局。
局限性
- 样本量小(19例),为单中心连续病例系列,随访中位2.4年。
- 所有患者均为WHO I级,结果可能不适用于其他级别肿瘤。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ABTRACT: BACKGROUND: Most spheno-orbital meningioma series span multiple decades, and predictors of visual outcomes have not yet been systemically assessed. We describe visual outcomes in a recent cohort and assess predictors of postoperative visual outcomes. METHODS: Consecutive case series operated by a team of a neurosurgeon and orbital surgeon between May 2015 and January 2019. Best corrected visual acuity (BCVA), visual fields (static perimetry), and relative proptosis were measured preoperatively and postoperatively at 3/6/12 months after which it was assessed yearly. Predictors were assessed with linear regression analysis. RESULTS: Nineteen patients (all WHO grade I) were operated by the pterional approach (median follow-up 2.4 years). Preoperative visual acuity deficits (n = 10) normalized in 70% and improved in 10% (median preoperative: 0.8, postoperative: 1.2, p = 0.021). Preoperative visual field deficits (n = 8) normalized in all patients (preoperative: - 6.5 dB, postoperative: - 1.5 dB, p = 0.008). Preoperative proptosis (n = 16) normalized in 44% and improved in 56% (preoperative: 5 mm, postoperative: 2 mm, p < 0.001). BCVA and visual fields remained stable at longer follow-up in 95% of patients, while 21% showed progression of proptosis. Predictors for worse longer-term (> 12 months) BCVA were worse preoperative BCVA (p = 0.002) and diagnosis of multiple meningioma (p = 0.021). Predictors for worse longer-term visual fields were higher diameter of hyperostosis (p = 0.009) and higher Simpson grade (p = 0.032). Predictor for short-term (3 months) proptosis was preoperative proptosis (p = 0.006). CONCLUSION: We recommend surgery, even of patients with minimal visual impairment or hyperostosis, as patients who present with deteriorated visual function or extensive hyperostosis are less likely to have postoperative visual outcomes restored to normal.
引用
- Zamanipoor Najafabadi AH, Genders SW, van Furth WR, et al. Visual outcomes endorse surgery of patients with spheno-orbital meningioma with minimal visual impairment or hyperostosis. Acta Neurochir (Wien). 2020. PMID: 32888075. doi:10.1007/s00701-020-04554-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。